SCHEMBL6136002

SCHEMBL6136002

Cc1ccc(N(C)C(=O)NCc2ccc(Cc3c(-c4ccc(O)cc4)ccc4cc(O)ccc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 2/20 0.43
▸ ESR2 Q92731 2/20 0.43
▸ MAOB P27338 2/20 0.39
▸ KDM4E B2RXH2 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ HTT P42858 2/20 0.38
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ ROCK2 O75116 1/20 0.33
▸ RORC P51449 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ PTPN1 P18031 1/20 0.33
▸ ACP1 P24666 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ MIF P14174 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6136101 0.96 ESR1 (0.46) ESR1ESR2MAOBROCK2HDAC1
SCHEMBL6136079 0.91 ESR1 (0.42) ESR1ESR2MAOBMEN1KMT2A
SCHEMBL6136484 0.91 ESR1 (0.44) ESR1ESR2MAOBRORCHDAC1
SCHEMBL6136242 0.90 ESR1 (0.47) ESR1ESR2NPC1RAB9AMEN1
SCHEMBL6136130 0.90 ESR1 (0.41) ESR1ESR2MAOBKDM4EALDH1A1
SCHEMBL6136160 0.85 ESR1 (0.44) ESR1ESR2HDAC1PTPN1ACP1
SCHEMBL6136240 0.83 NPC1 (0.53) ESR1ESR2NPC1RAB9AMEN1
SCHEMBL6136098 0.83 ESR1 (0.39) ESR1ESR2RAB9AMEN1KMT2A
SCHEMBL6136061 0.81 ESR1 (0.41) ESR1ESR2MAOBMEN1KMT2A
SCHEMBL6135927 0.81 ESR1 (0.38) ESR1ESR2MAOBROCK2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0895989-B1 1-[4-(Substituted alkoxy)benzyl] naphthalene compounds having estrogen inhibitory activity LILLY CO ELI (US) 2005-05-18 — — EP claimed
US-6509356-B1 Estrogen inhibitory activity method for the treatment of breast cancer in a woman comprising administering to a patient a therapeutically effective amount of a compound ELI LILLY AND COMPANY 2003-01-21 — — US claimed
WO-1999007377-A1 1-[4-(SUBSTITUTED ALKOXY)BENZYL]NAPHTHALENE COMPOUNDS HAVING ESTROGEN INHIBITORY ACTIVITY ELI LILLY AND COMPANY (US) 1999-02-18 — — WO claimed
EP-0895989-A1 1-[4-(Substituted alkoxy)benzyl] naphthalene compounds having estrogen inhibitory activity ELI LILLY AND COMPANY (US) 1999-02-10 — — EP claimed
EP-0895989-B1 1-[4-(Substituted alkoxy)benzyl] naphthalene compounds having estrogen inhibitory activity LILLY CO ELI (US) 2005-05-18 — — EP disclosed
US-6509356-B1 Estrogen inhibitory activity method for the treatment of breast cancer in a woman comprising administering to a patient a therapeutically effective amount of a compound ELI LILLY AND COMPANY 2003-01-21 — — US disclosed
WO-1999007377-A1 1-[4-(SUBSTITUTED ALKOXY)BENZYL]NAPHTHALENE COMPOUNDS HAVING ESTROGEN INHIBITORY ACTIVITY ELI LILLY AND COMPANY (US) 1999-02-18 — — WO disclosed
EP-0895989-A1 1-[4-(Substituted alkoxy)benzyl] naphthalene compounds having estrogen inhibitory activity ELI LILLY AND COMPANY (US) 1999-02-10 — — EP disclosed
Send feedback